ISSN: 1873-5576 (Online)
ISSN: 1568-0096 (Print)

Volume 16, 9 Issues, 2016

Download PDF Flyer

Current Cancer Drug Targets

Aims & ScopeAbstracted/Indexed in

Ranking and Category:
  • 68rd of 213 in Oncology

Submit Abstracts Online Submit Manuscripts Online

Ruiwen Zhang
Texas Tech University Health Sciences Center
1300 Coulter Drive
Amarillo, TX 79106

View Full Editorial Board

Subscribe Purchase Articles Order Reprints

Current: 3.707
5 - Year: 3.446

Upcoming Articles (E-Pub Abstracts ahead of Print)

High-throughput drug screening identifies pyrimethamine as a potent and selective inhibitor of acute myeloid leukemia

Amit Sharma, Nidhi Jyotsana, Courteney K. Lai, Anuhar Chaturvedi, Razif Gabdoulline, Kerstin Gorlich, Cecilia Murphy, Jan E. Blanchard, Arnold Ganser, Eric Brown, John A. Hassell, R. Keith Humphries, Michael Morgan and Michael Heuser.

View Abstract

Urotensin-II receptor: a double identity receptor involved in vasoconstriction and in the development of digestive tract cancers and other tumors

Alessandro Federico, Silvia Zappavigna, Marcello Dallio, Gabriella Misso, Francesco Merlino, Carmelina Loguercio, Ettore Novellino, Paolo X Paolo Grieco and Michele Caraglia.

View Abstract

MT1-MMP Activation of TGF-β Signaling Enables Intercellular Activation of an Epithelial-mesenchymal Transition Program in Cancer

Hoang-Lan Nguyen, Pournima Kadam, Kevin Cao, Song Wu, Ghassan J. Samara, Qian Zhang, Stanley Zucker and Jian Cao.

View Abstract View on PubMed

Novel strategies to discover effective drug targets in metabolic and immune therapy for glioblastoma

Gang Wang, Xing-Li Fu, Jun-Jie Wang, Rui Guan and Xiang-jun Tang.

View Abstract

Deregulation of apoptosis – is it still an important issue in pathogenesis of chronic lymphocytic leukemia?

Monika Podhorecka, Arkadiusz Macheta, Maria Bozko, Andrzej Bozko, Nisar P. Malek and Przemyslaw Bozko.

View Abstract

Discovery of a Novel Anti-Cancer Agent Targeting Both Topoisomerase I & II as well as Telomerase Activities in Human Lung Adenocarcinoma A549 Cells In Vitro and In Vivo: Cinnamomum verum Component Cuminaldehyde

Ta-Wei Chen, Kuen-daw Tsai, Shu-mei Yang, Ho-Yiu Wong, Yi-Heng Liu, Jonathan Cherng, Kuo-Shen Chou, Yang-Tz Wang, Janise Cuizon and Jaw-Ming Cherng.

View Abstract

CYR61 contributes to poor response to letrozole in ER positive breast carcinoma

Xiaoqing Jia, Guangyu Liu, Jingyi Cheng, Zhenzhou Shen and Zhimin Shao.

View Abstract

Targeting signaling pathways in chronic lymphocytic leukemia

Alice F. Muggen, Simar Pal Singh, Rudi W. Hendriks and Anton W Langerak.

View Abstract

Pax5 Re-Expression In H460 Cells Treated With The Combination Of Demethylating Agent And Histone Deacetylase Inhibitor Is Associated With The Enhancement Of P53 Binding To Pax5 Promoter Region

Yuanxin Liang, Jinwu Zeng, Linda Jelicks, Shengwei Ma, Jing Liu, Jingsong Mei, Roman Perez-Soler and Yiyu Zou.

View Abstract

E2F1 and NF-κB: Key Mediators of Inflammation-associated Cancers and Potential Therapeutic Targets

Yulin Huang, Rui Chen and Jianwei Zhou.

View Abstract

OncomicroRNAs-mediated tumorigenesis: implication in cancer diagnosis and targeted therapy

Nana Zheng, Ping Yang, Zhiwei Wang and Quansheng Zhou.

View Abstract

miR-137 suppresses the phosphorylation of AKT and improves the dexamethasone sensitivity in multiple myeloma cells via targeting MITF

Benping Zhang, Ling Ma, Jia Wei, Jingyu Hu, Zichu Zhao, Youping Wang, Yan Chen and Fei Zhao.

View Abstract

BRCA1-associated triple-negative breast cancer and potential treatment for ruthenium-based compounds

Khwanjira Hongthong and Adisorn Ratanaphan.

View Abstract

Anticancer Potential and Molecular Targets of Pristimerin: A mini-review

Bashir A. Yousef, Hozeifa M. Hassan, Lu-Yong Zhang and Zhen-Zhou Jiang.

View Abstract

RBM15 functions in Blood diseases

Mengyu Hu, Yuxia Yang, Zhi Ji and Jianyuan Luo.

View Abstract


Livia Manzella, Elena Tirrò, Maria Stella Pennisi, Michele Massimino, Stefania Stella, Chiara Romano, Silvia Rita Vitale and Paolo Vigneri.

View Abstract

nMET, a new target in recurrent cancer

Yingqiu Xie, Sholpan Istayeva, Zhanlin Chen, Tursonjan Tokay, Zhaxybay Zhumadilov, Denglong Wu, Gonzalo Hortelano and Jinfu Zhang.

View Abstract

Epi-drugs and Epi-miRs: Moving beyond current cancer therapies

Reza Salarini, Amirhossein Sahebkar, Hamid Reza Mirzaei, Mahmoud Reza Jaafari, Maryam Matbou Riahi, Jamshid Hadjati, Mobina Ostadi Asrami, Sara Fdaee, Rasoul Salehi and Hamed Mirzaei.

View Abstract

MicroRNA as regulators of cancer stem cells and chemoresistance in colorectal cancer

Xiaoming Liu, Qi Fu, Yong Du, Yinxue Yang and William C Cho.

View Abstract


Related Journals

Related eBooks

Webmaster Contact: Copyright © 2016 Bentham Science